Details of Drug

Details of Drug

 Drug General Information (ID: D1875)
  Drug Name
Ranibizumab (ophthalmic)
  Drug Type Monoclonal antibody
  Drug Synonymous
Ranibizumab; Ranibizumab biosimilar pf582; SB-11; SB11 (RANIBIZUMAB BIOSIMILAR); CHEMBL1201825
    Click to Show/Hide
  Therapeutic Class Anti-Angiogenic Ophthalmic Agents
  External Link
CHEBI ID CHEMBL:1201825

Drug-Drug Interaction Network
  Sunburst Graph
AM006  Pharmacodynamic additive effects
BM109  Increased risk of other adverse reactions (Unspecific)
  Relation Graph
 Full list of drugs interacting with Ranibizumab (ophthalmic)
      Pharmacodynamic additive effects
   Increased risk of other adverse reactions (Unspecific) Drug Num:  1
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1691
 
Verteporfin
 
C82H84N8O16
 
11980904 
Moderate    Inter Info   
[1]
References
1 Product Information. Lucentis (ranibizumab ophthalmic). Genentech, South San Francisco, CA.